Bourget said:
Yes, you're right Rupe, there is no end. I figured since I'm 41 and not producing much Test anyway I might as well just stay on Test in between cycles.
Your responce certainly makes sense. Does it pay to take the HCG, Clomid and Arimidex even though I continue with the test?
In my humble opinion, even though you're 41, you don't need to stay on Test 'forever". I think you would benefit more by taking breaks and giving your body and receptors a rest.
I'm older than you by a few years and my AAS usage is very conservative. To answer your question I have to admit I don't know for sure because you'll still have the negative feedback loop issue. I do know that when I cycle off I do an aggressive PCT and since I've added Proviron my sex drive is through the roof.
I am one of the few guys on here who supports a higher than normal HCG protocol, based on research I've read.
The cool thing is you can test my theory and see if your ability to orgasm changes. If not you can always go back to doing what you were doing before.
I'd cut the Test dose in half, then taper off and THEN 2 weeks later I'd add HCG 2500iu loading dose and then use about 5000iu's a week for 4 weeks, combined with Clomid, and an anti-e.
Plus throw in the proviron and maybe increase to 100mg/ed.
If you do a search on the board you will see some of the studies I have found on using HCG to make infertile men fertile and the doses they used were 3,000 to 6,000iu's a week for 6 months, and they had incredible results in men being able to impregnate women.
AAS usage shuts down your testicles and then you have all the other issues.
Hit the link and you'll find an extremely long but very well written study on long term AAS and azoospermia.
Again it's a LONG read, but incredible in detail.
http://www.mesomorphosis.com/articles/scally/anabolic-steroid-induced-hypogonadism.htm
"
The normal operation of both the testicular and hypothalamic-pituitary regions is crucial in returning HPTA function to normal. Returning one component of the axis to normal without concurrently returning the other would sabotage and inhibit the operation of the entire HPTA. The ability to produce a cure whereby there is no longer a need for medication is small. Discounting costs and focusing strictly on medicine reasons for this include inadequate stimulation for a critical part of the HPTA for full restoration, secondary inhibition of the HPTA, inadequate follow up and monitoring, and compliance due to the length of time the medicines are prescribed.
The individual use of human chorionic gonadotropin (hCG), clomiphene citrate, and tamoxifen citrate in the treatment of testicular sub-function and gonadotropin suppression, respectively, is well documented. The medicines utilized for the protocol used to normalize the HPTA come from the scientific literature detailing treatments of portions of the HPTA axis. In accordance with previous studies, each medication was used individually, and along with hCG, in initial trials.
The simultaneous use of clomiphene citrate and tamoxifen was determined through preliminary use of clomiphene citrate and tamoxifen, individually. It was discovered that although both clomiphene citrate and tamoxifen met with some success, when combined together they achieved a more significant increase in gonadotropin production. This clinical outcome resulted in the combination therapy of hCG, clomiphene citrate and tamoxifen.
These medicines hCG, clomiphene citrate and tamoxifen, with each being given over a defined period and for specific but related problems. The successful restoration of the HPTA requires the medications to be taken as prescribed. Every effort should be made to adhere to the schedule since the goal is to try and mimic the circadian rhythm that exists normally for the HPTA. hCG needs to be at a dose sufficient to stimulate testicular testosterone production. Also, the schedule for hCG is determined by when your own body should be attempting to produce its own testosterone. This is the ideal situation when AAS cessation date is known along with the type and dose of AAS being prescribed.